European commercialization introduces an additional aflibercept biosimilar option for major retinal indications, potentially ...
Tornambe published experiences in 302 eyes, in which he found a single injection attachment rate of 68% and a final attachment rate after reoperations of 95%, with a minimum follow-up of 6 months. He ...
ANN ARBOR, Mich., April 12, 2023 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal ...
Fluoroquinolone Use Linked to Retinal Detachment Current oral antibiotic use increases retinal detachment risk, but absolute risk is small, results of a case-control study indicate. HealthDay News — ...
CAMBRIDGE, Mass., April 10, 2025 /PRNewswire/ -- Pykus Therapeutics, Inc. ("Pykus" or the "Company") announced today that it has completed enrollment of its pilot study (PYK-2101-RD001) in Australia.
An AI-assisted model based on 71 different blood proteins could help doctors better predict retinal degeneration in diabetic ...
A history of atopic dermatitis (AD) is associated with an increased risk for retinal detachment (RD), according to a study ...
Please provide your email address to receive an email when new articles are posted on . Retinal re-detachment after cataract extraction can still occur in patients who previously underwent pars plana ...
Obviously the goal of retinal detachment repair is to reattach the retina. The patient however, does not care about anatomy. Success for the patient is that vision in macula-on detachments is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results